The Ritedose Corporation, Columbia, SC
Is The Ritedose Corporation registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does The Ritedose Corporation hold a South Carolina pharmacy license?
State board of pharmacy records for South Carolina are not checked: the Department of Labor, Licensing and Regulation’s board website did not respond to this index’s requests on November 6, 2026, or when tried again on November 7, 2026. The Delaware Division of Professional Regulation also lists nonresident license AD-0010076 for The Ritedose Corporation, COLUMBIA, SC, status Closed and license AD-0010081 for The Ritedose Corporation, COLUMBIA, SC, status Closed, as of Nov 10, 2026.
Has The Ritedose Corporation had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 FMD-145 letter (Sep 23, 2022) for The Ritedose Corporation. State board of pharmacy records for South Carolina are not checked: the Department of Labor, Licensing and Regulation’s board website did not respond to this index’s requests on November 6, 2026, or when tried again on November 7, 2026.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- The Ritedose Corporation
- Location
- Columbia, SC
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 1
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Sep 23, 2022
- FDA Data Dashboard inspections
- 12 inspections: 5 VAI, 7 NAI; 1 published Form 483
- Form 483 text on this page
- 1 Form 483, 1 observation
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as The Ritedose Corporation, a 503A facility, with 2 dated actions.
| Document | |||
|---|---|---|---|
| Sep 23, 2022 | FMD-145 letter | FMD-145 Letter Issued 09/23/2022 | Not linked by FDA |
| Mar 18, 2022 | Form 483 | 483 Issued 03/18/2022 | FDA copy (archived) |
A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists The Ritedose Corporation, Columbia, SC (FEI number 3001237796), matched to this page by exact name, city and state. It lists 12 inspections: 5 VAI, 7 NAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Feb 28, 2025 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3001237796 | 1250871 |
| Mar 22, 2022 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3001237796 | 1165123 |
| Apr 18, 2019 | No Action Indicated (NAI) | Bioresearch Monitoring (Drugs) | 3001237796 | 1089541 |
| Mar 3, 2017 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs): Voluntary Action Indicated (VAI); Compliance: Devices (Devices): Voluntary Action Indicated (VAI) | 3001237796 | 1015894 |
| Jul 31, 2015 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3001237796 | 940802 |
| Apr 17, 2014 | No Action Indicated (NAI) | Drug Quality Assurance (Drugs) | 3001237796 | 879447 |
| Nov 8, 2012 | No Action Indicated (NAI) | Drug Quality Assurance (Drugs) | 3001237796 | 835663 |
| Sep 9, 2011 | No Action Indicated (NAI) | Drug Quality Assurance (Drugs): No Action Indicated (NAI); Compliance: Devices (Devices): No Action Indicated (NAI) | 3001237796 | 744752 |
| Jan 6, 2011 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3001237796 | 712127 |
| Sep 30, 2010 | No Action Indicated (NAI) | Bioresearch Monitoring (Drugs) | 3001237796 | 685775 |
| Aug 12, 2010 | No Action Indicated (NAI) | Drug Quality Assurance (Drugs): No Action Indicated (NAI); Compliance: Devices (Devices): No Action Indicated (NAI) | 3001237796 | 676236 |
| Sep 18, 2009 | No Action Indicated (NAI) | Drug Quality Assurance (Drugs): No Action Indicated (NAI); Compliance: Devices (Devices): No Action Indicated (NAI) | 3001237796 | 618185 |
Form 483s FDA has published for this site
- Mar 18, 2022: Form 483 to The Ritedose Corporation, published Jun 13, 2022. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA’s published Form 483 for this site has 1 numbered observation in all. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.
Inspection Mar 7, 2022 to Mar 18, 2022: 1 observation
- Firm on the cover
- The Ritedose Corporation, 1 Technology Cir, Manufacturer
- FEI number
- 3001237796
- FDA district office on the cover
- 60 Eighth Street NE Atlanta, GA 30309
- Matched to this page by
- FEI number on the cover; linked from actions page, Data Dashboard
- FDA document
- Read the full 483 (PDF on fda.gov)
Observation 1
There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed.
Specifically, your firm detected mold species inside ISO 5 classified areas <Redacted B4> separate monitoring events between Januaiy 28, 2021 and November 05, 2021; six (6) of which recovered Aspergillus brasiliensis. Your firm did not thoroughly investigate these mold detection events and did not perform adequate actions to connect the issues and prevent recurrence.
State board of pharmacy records
State board of pharmacy records for South Carolina are not checked: the Department of Labor, Licensing and Regulation’s board website did not respond to this index’s requests on November 6, 2026, or when tried again on November 7, 2026.
Nonresident licenses in other states
These boards list a nonresident license whose record names this pharmacy’s own name, city and state.
Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| AD-0010076 | Outsourcing Facility-Distributor | The Ritedose Corporation | COLUMBIA, SC | Closed |
| AD-0010081 | Outsourcing Facility-Distributor | The Ritedose Corporation | COLUMBIA, SC | Closed |
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: FDA Form 483 Frequently Asked Questions
- Delaware Division of Professional Regulation license file
- Delaware Division of Professional Regulation disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.